Business July 27, 2026 at 5:18 PM

AstraZeneca shares climb after earnings beat estimates as cancer drug portfolio drives strong growth

Livemint Markets

Adjusted earnings per share, excluding certain items, climbed 21% to $2.63 in the latest quarter, comfortably surpassing analysts' expectations

USA-BONDS/ (UPDATE 2):TREASURIES-US yields decline as oil plunges

Paramount paused its $111 billion Warner Bros. merger to fast-track a court trial as states challenge the deal over comp…

Gold and silver prices gained on 27 July, buoyed by reduced tensions in the Middle East and lower crude oil costs ahead …

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play